![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
OraSure Technologies Inc | NASDAQ:OSUR | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.12 | 2.79% | 4.42 | 4.41 | 4.42 | 4.43 | 4.315 | 4.33 | 173,059 | 16:30:58 |
LOS ANGELES, March 25, 2013 /PRNewswire/ -- OraSure Technologies, Inc. (NASDAQ:OSUR), maker of the OraQuick® In-Home HIV Test, announced today the launch of a nationwide awareness campaign to encourage everyone to learn their HIV status. The campaign, "Make Knowing Your Thing Today" asks people across the country to share their story about their decision to test for HIV.
(Photo: http://photos.prnewswire.com/prnh/20130325/PH82934-a )
(Photo: http://photos.prnewswire.com/prnh/20130325/PH82934-b )
Earvin "Magic" Johnson has teamed with OraSure to kick off this campaign today, sharing his story of knowing, and encouraging others to do the same.
The OraQuick® In-Home HIV Test is the first ever in-home rapid infectious disease test made available directly to consumers. Launched in October 2012, the test detects antibodies to both HIV-1 and HIV-2 with an oral swab, providing a confidential in-home testing option with results in as little as 20 minutes. It is available in most national drugstore and mass merchandiser retail outlets nationwide and online at OraQuick.com.
Media Contact: Jennifer Moritz Zer0 to 5ive for OraSure Technologies 917-748-4006 jmoritz@0to5.com
SOURCE OraSure Technologies, Inc.
Copyright 2013 PR Newswire
1 Year OraSure Technologies Chart |
1 Month OraSure Technologies Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions